Indeed, we and others previously found that COVID-19 patients with neurological complications had elevated serum immune mediators and cytokines (IL-6, IL-12p40, IL1-RA, M-CSF, CCL2, and HGF) which correlated with serum brain injury markers (7–10). Here, CCL2 is linked to COVID-19.